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Estadiamento e grau de resiliência do sobrevivente ao câncer 
de mama
Staging and resilience degree in breast cancer survivors
Estadificación y grado de resiliencia del sobreviviente de cáncer de mama
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ABSTRACT
Objective: To assess the resilience and staging degree relating to sociodemographic factors of breast cancer 
survivors followed up in an oncology service. Method: Quantitative study with 112 breast cancer survivors. 
The variables selected were: sociodemographic; clinical staging; survival time; and resilience scale. The analysis 
was performed using the Epi Info 6.04 software and Fisher’s exact test. The research was approved by the Ethics 
Committee of the Federal University of Pelotas School of Nursing under Opinion Nº 31/2009. Results: The 
average age was 46.2 years, there was 60.71% of stage II cases, 81.25% were white, 40.18% had five-to eight-year 
schooling, 52.68% were married, 73.32% had lived in urban areas, 41.96% exhibited high resilience, and 48.21% 
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were followed up from one to three years. Conclusion: 
Staging was not associated with the resilience degree, but 
rather with age and survival time, confirming the findings 
of other studies. 
Descriptors: Breast Neoplasia, Neoplasia Staging, 
Psychological Resilience.
RESUMO
Objetivo: Investigar o grau de resiliência e de estadiamento frente 
aos fatores sociodemográficos dos sobreviventes ao câncer de mama 
em acompanhamento em um serviço de oncologia. Método: Estudo 
quantitativo com amostra de 112 sobreviventes ao câncer de mama. Foram 
selecionadas variáveis sociodemográficas, estadiamento clínico, tempo 
de sobrevida e escala de resiliência. A análise foi realizada utilizando o 
software Epi Info 6.04 e o teste exato de Fisher. A pesquisa foi aprovada 
pelo Comitê de Ética da Faculdade de Enfermagem da Universidade 
Federal de Pelotas sob o Parecer nº 31/2009. Resultados: A média de idade 
foi de 46,2 anos, houve 60,71% de estadiamento II, 81,25% eram brancos, 
40,18% tinham escolaridade entre cinco e oito anos, 52,68% eram casados, 
73,32% havia vivido em zona urbana, 41,96% apresentou alta resiliência 
e 48,21% mantinha-se em acompanhamento entre um e três anos. 
Conclusão: O estadiamento não esteve associado ao grau de resiliência, 
mas sim à idade e tempo de sobrevida, confirmando os achados em outros 
estudos. 
Descritores: Neoplasias da Mama, Estadiamento de Neoplasias, 
Resiliência Psicológica.
RESUMEN
Objetivo: Investigar el grado de resiliencia y estadificación en relación 
con factores sociodemográficos de sobrevivientes de cáncer de mama en 
seguimiento en un servicio de oncología. Método: Estudio cuantitativo 
con 112 sobrevivientes de cáncer de mama. Las variables seleccionadas 
fueron: sociodemográficas; estadificación clínica; tiempo de sobrevida; 
y escala de resistencia. El análisis se realizó utilizando el software Epi 
Info 6.04 y el test exacto de Fisher. La investigación fue aprobada por el 
Comité de Ética de la Facultad de Enfermería de la Universidad Federal 
de Pelotas con el Dictamen Nº 31/2009. Resultados: La edad promedio 
fue de 46,2 años, 60.71% estaban en estadio II, 81.25% eran blancos, 
40.18% tenían escolaridad entre cinco y ocho años, 52.68% eran casados, 
73.32% habían vivido en zonas urbanas, 41.96% tuvieron alta resiliencia 
y el 48,21% estaban en seguimiento entre uno y tres años. Conclusión: La 
estadificación no estuvo asociada al grado de resiliencia, sino a la edad y 
tiempo de sobrevida, confirmando los hallazgos de otros estudios. 
Descriptores: Neoplasia de Mama, Estadificación de Neoplasias, 
Resiliencia Psicológica.
INTRODUCTION
Breast cancer is the most common and the second bigger 
cause of death from cancer among Western women. The 
average risk of developing the disease among these women 
is from one to eight, with lower incidence in some other 
regions of the world and non-Caucasians.¹
Due to its high frequency and, above all, the psychological 
effects on the perception of sexuality and personal image, 
breast cancer is probably one of the most feared among 
women.² Estimates for 2012/2013 were not very encouraging, 
because there was an estimate of 52,680 new cases in Brazil, 
which is equivalent to 27.9% of female cancers.³
There has been a small fall in mortality rate in the last 
20 years. This scenario may be associated with increased 
early diagnosis resulting from campaigns that encourage 
the implementation of screening mammography. This way, 
when tumors are diagnosed early, they are in the initial stage 
with small size and and, consequently, better diagnoses 
are possible.4
Staging a case of malignant neoplasia allows assessing 
the degree of dissemination. Thus, the need of classifying the 
cases of cancer in stages is based on the ascertainment that 
the survival rates are unequal when the disease is limited to 
the organ of origin or when it disseminates into other organs. 
This way, it is possible to classify the evolution of neoplasias in 
order to determine the best treatment and patients’ survival.5
The history of breast cancer indicates that the clinical 
course of the disease and survival vary from patient to 
patient. This variation is determined by a complex series 
of factors, such as the difference in tumor doubling time, 
metastasization potential, tumor histological type, hormone 
receptor status, and other mechanisms which have not 
yet been fully understood and are related to the immune, 
hormonal, and nutritional condition of the patients.1
In addition to these factors, the ability to deal positively 
with adversity to overcome the condition, using adaptive 
resources to confront the reality, generates the resilience 
process. This process can make individuals more or less 
vulnerable to risk and, in addition, determine the way by 
which they can be resilient in the face of the adversities,6 
which may or may not be related to survival.
We have observed the absence of studies on resilience 
associated with clinical staging. This fact adds value to the 
present study as a contribution to encourage the conduction 
of further studies. Accordingly, the goal of the present 
study was to assess resilience and staging degree relating 
to sociodemographic factors in breast cancer survivors 
followed up in an oncology service in southern Brazil.
METHOD
The present study was conducted at the Oncology Service 
of the Federal University of Pelotas Teaching Hospital, 
Pelotas/RS. This service is considered a reference center for 
the treatment of cancer in that city and the southern region.
It is a descriptive, cross-sectional study with quantitative 
approach drawn from the research7 “Resilience as Coping 
Strategy for Cancer Survivors” coordinated by professor 
Rosani Manfrin Muniz. That research was conducted by the 
Federal University of Pelotas School of Nursing and approved 
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by the Ethics Research Committee of the institution under 
Opinion Nº 31/2009 on 17th August 2009.
The instrument used for the collection of data was 
a structured questionnaire containing 148 predefined 
questions. Eight questions were prepared using the medical 
records of the patients and 25 using Wagnild and Young 
Resilience Scale.8
The data relating to the present study were obtained 
from the database used in the abovementioned research 
and entered into the Epi info 6.04 software. The analysis was 
performed using the mentioned software and Fisher’s exact 
test. Of the 264 participants included in that database, we 
selected 112 patients diagnosed with breast cancer. These 
patients were 109 women and three men.
The sociodemographic variables selected were: age; sex; 
race; education; marital status; and place in which they had 
lived most of their lives – urban or rural area. In addition, 
other variables were chosen, namely: clinical staging of the 
disease (according to the patients’ medical records and not as 
recommended by the literature on breast cancer¹); survival 
time (considered from the end of treatment until the time 
of the interview, reported by the patients); and the resilience 
degree (Wagnild and Young Resilience Scale8,9,10).
The present study met the directives of Chapter III of the 
Ethics Code of Nursing Professionals, based on Resolution 
311/200711 of the Federal Nursing Council (COFEN) related 
to prohibitions and duties. The study also met Resolution 
Nº 196/9612 of the National Health Council concerning 
research involving humans.
The participants signed an informed consent form after 
being informed about the objectives of the research. Parti-
cipants’ anonymity and privacy were assured and they were 
free to withdraw from the study at any time.
Quality control was performed by means of the following 
procedures: application of data collection instruments; chec-
king performed by each interviewer at the end of the inter-
views; review performed by supervisors; replication of the 
questionnaire in 10% of the participants; and double data 
typing, followed by comparison of the databases and correc-
tion of inconsistencies.
RESULTS
Of the 264 participants included in the abovementioned 
research, 42.42% (112) had breast cancer diagnosis, 97.30% 
(109) were women and 2.67% (3) men. Table 1 presents the 
description of sociodemographic data of the participants 
with breast cancer. The average age was 46.2 years and the 
median 55 years (27 to 84 years). The age groups chosen and 
presented in Table 1 followed the recommendation of the 
Ministry of Health to conduct screening mammography.
Of the total of patients with breast cancer, 4.46% (5) were 
aged under 39 years, 56.25% (63) between 40 and 59 years, 
36.6% (41) between 60 and 79 years, and 2.68% (3) above 
80 years.
With respect to breast cancer staging, the highest 
incidence occurred in the group aged 50 to 69 years, with 
63.39% (71) of cases, with six in stage I, 46 in stage II, 12 
in stage III, and seven in stage IV. It is worth noting the 
presence of a few cases in early stage, with three cases in the 
group aged up to 49 years, six cases between 50 and 69 years 
of age, and one in the group of 70 years and over.
There was a predominance of stage II with 60.71% (68) 
of the participants, followed by stage III with 19.64% (22). 
Only 8.9% (10) of neoplasias had been diagnosed in stage I 
and there was no record of in situ stage. There were 8.9% (10) 
of neoplasis in stage IV and 1.8% (2) whose stages were not 
available in the medical records.
White race was prevalent in the participants, totaling 
81.25% (91). Of these, 78.57% (88) were women and 2.67% 
(3) men. There was 18.75% (21) of non-white patients.
The most frequent education level among the participants 
was five to eight years of study (40.18%; 45) and 8.03% 
(9) had 13 years and more. With respect to the percentage 
relating to the marital status of the population studied, it 
was found that: 52.68% (59) were married and, of these, 57 
were women and two men; 14.28% (16) were single, with 15 
women and one man; 14.28% (16) were separated/divorced; 
and 18.75% (21) were widow/widowed.
The place where the patients had lived most of their lives 
was predominantly urban, totaling 72.32% (81) in urban 
areas and 27.67% (31) in rural areas.
Table 1  – Description of patients with breast cancer by sex 
and staging according to sociodemographic data and loca-
tion where they lived most of their lives: Oncology Service 
of the Federal University of Pelotas Teaching Hospital, 2010
Breast cancer
Sex/Staging*
Female (n=109) Male (n=03)
 I       II       III       IV      N/A  I        II       III       IV     N/A
AGE
Up to 49 years 03 14 06 02 01
50 to 69 years 06 44 10 07 01 01
70 years and 
over
01 09 05 01 01
RACE
White 07 56 16 08 01 01 01 01
Non-white 03 11 05 02
EDUCATION
Illiterate 01 04 01
From 1 to 4 
years of study
02 17 09 03 01
From 5 to 8 
years of study
04 29 08 04 01 01
From 9 to 12 
years of study
03 12 01 01 01
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Breast cancer
Sex/Staging*
Female (n=109) Male (n=03)
 I       II       III       IV      N/A  I        II       III       IV     N/A
MARITAL STATUS
Married 06 35 09 06 01 01 01






03 15 02 01
Place where they lived most of their lives
Urban area 09 47 14 08 01 01 01
Rural area 01 20 07 02 01
Source: Research “Resilience as Coping Strategy for Cancer 
Survivors”, 2010. 
*Data found in the medical records of the patients; N/A = not available.
Table 2 presents the staging by sex, according to the 
resilience degree and survival of the participants with breast 
cancer. With respect to the resilience degree, 8.03% (9) of the 
interviewees exhibited low resilience, whereas 42.85% (48) 
exhibited high resilience against the situation experienced.
With respect to the survival time, 48.21% (54) had been 
followed up from one to three years; they were 52 women 
and two men. It is worth noting that there were eight women 
and one man who had been followed up from seven to nine 
years after completion of treatment. Two women had been 
followed up for more than 10 years, one in stage II and the 
other in stage III at the time of diagnosis and initiation of 
treatment.
Table 2 – Description of patients with breast cancer by sex 
and staging according to the resilience degree and survival 
time after completion of treatment, Oncology Service of the 
Federal University of Pelotas Teaching Hospital, 2010
Breast cancer
Sex/Staging
Female (n=109) Male (n=03)
 I        II       III       IV     N/A  I       II       III       IV      N/A
RESILIENCE
Low 01 05 02 01
Medium 04 35 11 03 01 01
High 05 27 08 06 01 01
SURVIVAL AFTER TREATMENT
Less than 1 year 04 06 02 03
From 1 to 3 years 02 32 11 07 01 01
From 4 to 6 years 01 26 01
From 7 to 9 years 03 01 03 01 01
10 years and over 01 01
N/A 01 03
Source: Research “Resilience as Coping Strategy for Cancer 
Survivors”, 2010. 
N/A = not available.
DISCUSSION
According to world statistics,13,4,5,6 breast cancer is rare in 
men, with a ratio of one man for every 70 to 130 women, 
i.e,. equivalent to one hundredth of female cases.¹ Therefore, 
women have a higher risk of developing this neoplasia.
Even in the face of breast cancer being rare in men, the 
percentage of the male population in the present study was 
greater than that found in the literature,¹ with 2.67% (3) of 
the total compared to the number of women.
Associated with sex, another major risk factor for the 
disease is age.17 The incidence of breast cancer is uncommon 
in young women, but it increases during aging.18
Among the participants, 80.35% (90) belonged to the age 
group between 40 and 69 years. This is the age group that 
stands out by the greatest prevalence of the disease and death 
from breast cancer.19 It is worth stressing the importance of 
preventive exams from the fourth decade of life, because, 
among the participants, the incidence was 50.89% (57) of the 
disease between the fourth and fifth decades.
The risk of developing breast cancer mentioned by a 
study was one in 14 women aged between 60 and 79 years, 
compared to one in 24 women aged between 40 and 59 years, 
and one in 228 women aged 39 years and below.20 Data from 
another study21 showed incidence of  5.6% of cases with ages 
of 40 years and below, which is similar to the data of the 
present study.
In other study,22 the average age among the participants 
with breast cancer was 56 years, with 21% of malignant 
pathology corresponding to women under the age of 45 
years. However, in our reality, there were few diagnoses in 
women under the age of 45 years, totaling 8.93% (10) of the 
participants and, of these, only one was in stage I.
Of the total, three women under the age of 45 years were 
in stage II and three in stage III, with survival between one 
and three years after completion of treatment at the time 
of the interview. According to Fisher’s exact test, there was 
a significant association (p = 0.009) between staging and 
survival time, in which survival ratings (<1 year and 1-3 
years) showed a higher frequency of the disease in stage IV.
In another study,23 the average age was 54 years, but 
with lower survival rate in women under the age of 30 years 
(47%). The present study found only one woman under the 
age of 30 years in stage II and she had been followed up from 
four to six years. Still, it is important to note that one woman 
aged 34 years was in stage I at the beginning of treatment and 
had been followed up from seven to nine years. Therefore, 
it is important to search for health services when changes 
in the body are observed and undergo treatment as well as 
follow-up after the completion of treatment.
In addition, factors that postpone the diagnosis of 
breast cancer in young women may be associated with the 
low level of clinical suspicion of the disease, the difficulty 
experienced during the examination of dense breasts, and 
lack of screening mammography in this group of patients.24
However, according to a study,25 breast cancer in 
young women is rarely found by the physician in the 
clinical examination of asymptomatic patients. This way, 
in most cases, breast cancer is diagnosed late with possible 
(Continuation)
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unfavorable prognosis. That study found that the greatest 
incidence during the postoperative period was stage IIA, 
corresponding to 33.1% of patients, followed by stage IIB, 
with 21.8%. These results were similar to those found in the 
present study, in which 60.71% of the patients were in stage 
II. On the other hand, with respect to the clinical staging 
obtained from the patients’ medical records, it was only 
described as stage II and stage III, and not as recommended 
by the literature for breast cancer.1,26
Regarding marital status and education, a study,27 in 
which 62 patients with breast cancer were interviewed, 79.0% 
(49), were married and 40.3% (25) had higher education. 
Different data were found in the present study, in which 
52.68% (59) of the patients were married and only 8.03% (9) 
had higher education.
However, it is assumed that women with higher 
education level seek health services more frequently. In this 
way, they are subjected to early clinical breast examination 
and screening mammography to detect breast cancer in 
initial stage.23
According to the same study,23 the risk of dying among 
illiterate women was up to seven times greater than 
among those women who had higher education. This fact, 
according to the author, may be related to the difficulty in 
understanding the performance of preventive exams and the 
difficulty of access to more effective health services for early 
diagnosis and initiation of treatment.
When it comes to the level of education, in 5.36% (6) 
of illiterate participants, the survival of two of them was 
lower than one year, in one participant it was from one to 
three years, in two participants from four to six years, and 
one participant could not inform the survival time when 
interviewed. In 48.21% (54) of the participants, survival was 
from one to three years. This group consisted of one illiterate, 
13 with one to four years of study, 25 with five to eight years, 
nine with nine to 12 years, and six with 13 years and over.
Regarding survival, a study23 indicated that women with 
higher level of education had longer survival (92.2%) during 
the five years assessed compared with women who had 
secondary education (84%), elementary education (73.6%), 
and those who were illiterate (56%).
In view of these results, it can be inferred that, due to 
low education level, there is no proper observation of the 
presence of early signs and symptoms, a fact that delays the 
seek for health services to perform early diagnosis. This way, 
it is necessary to conduct specific studies to assess this issue.
The Consensus on Breast Cancer Control28 suggests 
that screening mammography should be performed from 
the age of 50 years. However the present study found that 
23.21% (26) of the cases were diagnosed under this age, and 
89.28% (100) of the cases were in stage II or higher at the 
time of diagnosis.
Regarding race, the present study found a predominance 
of white population with 81.25% (91) of the participants 
and, grouping the non-white participants, there was 
18.75% (21) of participants. The predominant race found 
in other studies29,30 was also white. According to statistical 
data31 and another study,32 the population of the region 
served was predominantly white. This finding explains 
the predominance of this population in the present study. 
Another study23 revealed that white patients had longer 
survival (76.9%) compared with non-white participants 
grouped (62.2%).
In the present study, survival relating to race was 36.61% 
(41/91) of the white population with a survival rate between 
one and three years, followed by 11.61% (13/21) of non-white 
individuals grouped with equal survival. Despite knowing 
the factors associated with this neoplasia, about 60% of the 
cases in Brazil are still diagnosed at advanced stages.33 This 
percentage was confirmed by the present study.
Estimates are varied for different stagings and these 
differences are alarming. In breast cancer patients with stage 
zero or I, only one in eight dies within ten years, of those 
diagnosed in stage II a third dies within ten years, and stages 
III and IV have very dismal prognosis, because very few 
women with stage IV remain alive after 10 years.34
In the present study, only one woman with stage II and 
another with stage III at the time of diagnosis were alive and 
being followed up for more than 10 years. These findings are 
in line with those found in a study conducted more than 20 
years ago.34
With respect to staging, a study35 found that 45.6% of 
the cases were localized, 19.7% were regional, 10.2% had 
distance metastasis at the time of diagnosis, and 4.2% had 
in situ tumors. However, that study did not inform about 
the staging of the disease at diagnosis in 20.3% of cases. The 
present study showed that only 1.78% (2) of the cases did 
not have information about staging in the medical records 
and staging of in situ neoplasias was not recorded. This fact 
can be associated with late search of health services after 
the appearance of the first symptoms and the difficulties 
in accessing those services, thus delaying diagnosis and 
initiation of treatment.
In addition, there are individuals who live in 
disadvantaged sociocultural environments. Among these, 
there are individuals who live in rural areas and have 
difficulties relating to distance and lower availability of access 
to cancer education programs and general information.36
Since breast cancer is a disease that causes significant 
morbimortality, late diagnosis lessens the possibility of 
satisfactory treatment. It should be noted that the rural 
population experiences difficulties in obtaining the 
diagnosis; however, on the other hand, they do not exhibit 
different stages compared with those found in the urban 
population.37 The present study also found this reality, since 
the rural population did not exhibit significant differences in 
staging compared with the urban population.
Still, regarding the ability to cope with the disease 
process, overcoming barriers, and becoming stronger with 
respect to the experienced situation, 8.03% (9) exhibited low 
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resilience and 42.85% (48) exhibited high resilience. On the 
other hand, there was no significant association between 
staging and resilience (p = 0.81 - Fisher’s exact test).
This way, it is worth noting that the degree of staging 
did not interfered with the way to overcome the difficulties 
during the follow-up process after the completion of 
treatment in breast cancer survivors of the present study. 
There were no significant differences between the resilience 
degree at different staging degrees.
It is possible to highlight that 91.96% (103) of breast 
cancer survivors developed ability to respond positively 
to the adverse situations they faced during the disease 
process. These survivors exhibited medium (50%) and high 
resilience (41.96%).
However, some individuals with similar trajectories can 
differentiate themselves by the fact that some of them can 
overcome the adversities, whereas other individuals have 
more difficulties in overcoming these situations and others 
are not able to face them.38
CONCLUSIONS
The knowledge about the profile of breast cancer 
survivors can provide them and health managers further 
information about the disease and its epidemiology. The 
results of the present study showed small percentage of 
survivors diagnosed in initial stage. However, in Brazil, 
with increasingly frequent performance of screening 
mammography, breast cancer has been diagnosed in earlier 
stages. Accordingly, survival and the possibility of cure have 
also increased.
It was also observed that there was a greater incidence 
of breast cancer between the fourth and fifth decades of life. 
Therefore, it is important to stimulate men and women to 
pay attention to any changes in their breasts.
Breast cancer in individuals younger than 40 years is 
unusual.39 However, after this age, annual clinical breast 
examination and screening mammography, at least every 
two years, will contribute to an early diagnosis.40
The present study sought results that could indicate an 
association between clinical staging and resilience capacity in 
breast cancer survivors. The expectation was to find a lower 
resiliency degree relating to higher staging degree. However, 
it was found that this association was not significant and, 
therefore, this hypothesis was not confirmed.
Based on the findings of the present study, it is worth 
mentioning the importance of intensifying actions in order 
to raise awareness about the need of breast cancer detection. 
This process will lead to diagnosis in earlier stages of this 
neoplasias, thus enabling a greater survival rate. However, 
it is known that this survival rate depends largely on the 
conditions of access to health services, in addition to the 
quality of care provided to this population after the diagnosis.
Still, there is shortage of studies assessing staging, 
survival, and the resilience process. This way, these studies 
are recommended so that professionals who work in the 
oncology field can help the population to become stronger to 
cope with the cancer experience and enhance the possibility 
of having better quality of life during the survival period.
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